Due to the findings of this study the surgeons have begun AF-treatment of more patients undergoing GI-surgery in which through experience the outcome is known to lead to reduced intestinal function.
The treatment is initiated by already on the first day administer Salovum® dissolved in ordinary juice. This will quickly lead to high AF levels in the intestine without first letting the body produce it by its own. Most often the patients initially treated with Salovum® for 5-10 days can then be transferred to the AF inducing SPC-Flakes® in order to stimulate the endogenous AF production.
Björck, Bosaeus, Ek, Jennische, Lönnroth, Johansson and Lange, Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: A study of a concept, Gut, 2000; 46:824-829, view link
SPC-Flakes® in IBD in children
The first pilot study in children with ulcerative colitis and Crohn's disease revealed that the clinical symptoms improved and that treatment with SPC-Flakes® is a safe and well tolerated treatment. The positive study results will be followed up with a randomised double-blind study.
Finkel, Bjarnason, Lindblad and Lange, Specially Processed Cereals: A clinical innovation for children suffering from inflammatory bowel disease?, Scand J of Gastroenterol, 2004; 39:87-88, view link